2024 NOSCM | Selecting the Best Frontline Therapy for Transplant Eligible Myeloma Patients

2024 NOSCM | Selecting the Best Frontline Therapy for Transplant Eligible Myeloma Patients

Overview

NA

Target Audience

NA

This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.

Faculty

Saad Usmani, MD, MBA, FACP

Date of Release

May 14th, 2025